VolitionRX Ltd (AMEX: VNRX) on Tuesday, plunged -9.97% from the previous trading day, before settling in for the closing price of $0.33. Within the past 52 weeks, VNRX’s price has moved between $0.31 and $0.94.
During the last 5-year period, the sales growth of Healthcare Sector giant was 5.38%. The company achieved an average annual earnings per share of 31.18%. With a float of $96.62 million, this company’s outstanding shares have now reached $109.62 million.
VolitionRX Ltd (VNRX) Insider Activity
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of VolitionRX Ltd is 21.32%, while institutional ownership is 21.27%. The most recent insider transaction that took place on Nov 17 ’25, was worth 7,000. In this transaction President and CEO of this company bought 20,000 shares at a rate of $0.35, taking the stock ownership to the 2,554,847 shares. Before that another transaction happened on Oct 14 ’25, when Company’s President and CEO bought 110,000 for $0.51, making the entire transaction worth $56,100. This insider now owns 2,534,847 shares in total.
VolitionRX Ltd (VNRX) Earnings and Forecasts
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.06 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.05) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 31.18% per share during the next fiscal year.
VolitionRX Ltd (AMEX: VNRX) Trading Performance Indicators
VolitionRX Ltd (VNRX) is currently performing well based on its current performance indicators. A quick ratio of 0.12 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 24.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.23, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -0.11 in one year’s time.
Technical Analysis of VolitionRX Ltd (VNRX)
Looking closely at VolitionRX Ltd (AMEX: VNRX), its last 5-days average volume was 7.11 million, which is a jump from its year-to-date volume of 0.47 million. As of the previous 9 days, the stock’s Stochastic %D was 14.35%.
During the past 100 days, VolitionRX Ltd’s (VNRX) raw stochastic average was set at 0.77%, which indicates a significant decrease from 2.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0363 in the past 14 days, which was lower than the 0.0451 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4794, while its 200-day Moving Average is $0.5704. However, in the short run, VolitionRX Ltd’s stock first resistance to watch stands at $0.3371. Second resistance stands at $0.3754. The third major resistance level sits at $0.3964. If the price goes on to break the first support level at $0.2778, it is likely to go to the next support level at $0.2568. Should the price break the second support level, the third support level stands at $0.2185.
VolitionRX Ltd (AMEX: VNRX) Key Stats
Market capitalization of the company is 36.71 million based on 122,802K outstanding shares. Right now, sales total 1,230 K and income totals -26,970 K. The company made 630 K in profit during its latest quarter, and -5,380 K in sales during its previous quarter.
